| 2012 revised international chapel hill consensus conference nomenclature of vasculitides JC Jennette, RJ Falk, PA Bacon, N Basu, MC Cid, F Ferrario, ... Arthritis & Rheumatism 65 (1), 1-11, 2013 | 3350 | 2013 |
| Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies R Watts, S Lane, T Hanslik, T Hauser, B Hellmich, W Koldingsnes, A Mahr, ... Annals of the rheumatic diseases 66 (2), 222-227, 2007 | 810 | 2007 |
| Antineutrophil cytoplasmic antibodies and the Churg–Strauss syndrome R Sablé-Fourtassou, P Cohen, A Mahr, C Pagnoux, L Mouthon, D Jayne, ... Annals of internal medicine 143 (9), 632-638, 2005 | 639 | 2005 |
| Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis L Guillevin, C Pagnoux, A Karras, C Khouatra, O Aumaître, P Cohen, ... New England Journal of Medicine 371 (19), 1771-1780, 2014 | 541 | 2014 |
| Azathioprine or methotrexate maintenance for ANCA-associated vasculitis C Pagnoux, A Mahr, MA Hamidou, JJ Boffa, M Ruivard, JP Ducroix, ... New England Journal of Medicine 359 (26), 2790-2803, 2008 | 529 | 2008 |
| EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis B Hellmich, O Flossmann, WL Gross, P Bacon, JW Cohen-Tervaert, ... Annals of the rheumatic diseases 66 (5), 605-617, 2007 | 501 | 2007 |
| Long-term patient survival in ANCA-associated vasculitis O Flossmann, A Berden, K de Groot, C Hagen, L Harper, C Heijl, ... Annals of the rheumatic diseases 70 (3), 488-494, 2011 | 495 | 2011 |
| The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort L Guillevin, C Pagnoux, R Seror, A Mahr, L Mouthon, P Le Toumelin Medicine 90 (1), 19-27, 2011 | 472 | 2011 |
| Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group … C Comarmond, C Pagnoux, M Khellaf, JF Cordier, M Hamidou, JF Viallard, ... Arthritis & Rheumatism 65 (1), 270-281, 2013 | 447 | 2013 |
| Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg‐Strauss syndrome in a French urban multiethnic population in 2000: a capture … A Mahr, L Guillevin, M Poissonnet, S Aymé Arthritis Care & Research 51 (1), 92-99, 2004 | 445 | 2004 |
| Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta‐analysis AD Mahr, JA Jover, RF Spiera, C Hernández‐García, ... Arthritis & rheumatism 56 (8), 2789-2797, 2007 | 428 | 2007 |
| Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis RJ Falk, WL Gross, L Guillevin, GS Hoffman, DRW Jayne, JC Jennette, ... Arthritis & Rheumatism 63 (4), 863-864, 2011 | 425 | 2011 |
| Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody–associated vasculitis: A randomized controlled trial TF Hiemstra, M Walsh, A Mahr, CO Savage, K De Groot, L Harper, ... Jama 304 (21), 2381-2388, 2010 | 422 | 2010 |
| EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis M Yates, RA Watts, IM Bajema, MC Cid, B Crestani, T Hauser, B Hellmich, ... Annals of the rheumatic diseases 75 (9), 1583-1594, 2016 | 419 | 2016 |
| Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force C Mukhtyar, O Flossmann, B Hellmich, P Bacon, M Cid, ... Annals of the rheumatic diseases 67 (7), 1004-1010, 2008 | 346 | 2008 |
| Efficacy of the anti‐TNF‐α antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients P Bartolucci, J Ramanoelina, P Cohen, A Mahr, P Godmer, C Le Hello, ... Rheumatology 41 (10), 1126-1132, 2002 | 337 | 2002 |
| Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis … C Pagnoux, A Mahr, P Cohen, L Guillevin Medicine 84 (2), 115-128, 2005 | 330 | 2005 |
| Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the … C Pagnoux, R Seror, C Henegar, A Mahr, P Cohen, V Le Guern, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2010 | 329 | 2010 |
| Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients L Guillevin, A Mahr, P Callard, P Godmer, C Pagnoux, E Leray, P Cohen, ... Medicine 84 (5), 313-322, 2005 | 326 | 2005 |
| HLA–B51/B5 and the risk of Behçet's disease: A systematic review and meta‐analysis of case–control genetic association studies M de Menthon, MP Lavalley, C Maldini, L Guillevin, A Mahr Arthritis Care & Research 61 (10), 1287-1296, 2009 | 313 | 2009 |
Joël CosteParis Descartes University, Ecole Pratique des Hautes EtudesEmail verificata su parisdescartes.fr
